ELAN Elanco Animal Health Earnings and EPS analysis

Relative Growth: Rel. Growth: 30

Relative Strength: Rel. Strength: 75

Relative Valuation: Rel. Valuation: 27

Relative Profitability: Rel. Profitability: 32

EPS in 2026 (TTM): -$0.5

Last Report Period Date: Mar 31, 2026

As of June 2026, according to Elanco Animal Health's latest financial report, the company's current EPS (TTM) is -$0.5. In 2025, the company recorded an earnings per share (EPS) of -$0.47, which represents a decrease compared to its EPS of $0.68 in 2024. Elanco Animal Health's earnings per share for the quarterly report ending on Mar 31, 2026 was $0.11.

ELAN earnings history

Historical annual and quarterly earnings per share (EPS) data for Elanco Animal Health

EPS (TTM)

-$0.5

EPS Growth YoY (Quarterly)

-21.4%

EPS (Quarterly)

$0.11

EPS Growth (Quarterly)

119.6%

The annual EPS in 2025 was -$0.47, a decrease of 169.1% from $0.68 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.11, showing a 21.4% decrease from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is -$0.5. In 2024, the annual EPS was $0.68, showing an increase of 127.2% from 2023.

ELAN earnings chart

ELAN EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-21.4%

EPS growth YoY

-169.1%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Elanco Animal Health has recorded a decrease in EPS of 21.4% over the last 12 months (YoY, quarterly).

ELAN Earnings Waterfall

Breakdown of revenue, profit and net income for Elanco Animal Health

ELAN Earnings vs Peers

What are the earnings of ELAN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
OPK Opko Health Inc	N/A	-275%	N/A	N/A
ORGO Organogenesis Holdings Inc	N/A	1,700%	10.1%	0%
ELAN Elanco Animal Health Inc	N/A	-169.1%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.